Shital Gandhi1, Dongmei Sun2, Alison L Park3, Michelle Hladunewich1, Candice K Silversides4, Joel G Ray5. 1. Department of Medicine, Mt. Sinai Hospital, University of Toronto, Toronto ON; Obstetrical Medicine Program, University of Toronto, Toronto ON. 2. Department of Medicine, Western University, London ON. 3. Institute for Clinical Evaluative Sciences, Toronto ON. 4. Department of Medicine, Mt. Sinai Hospital, University of Toronto, Toronto ON; Obstetrical Medicine Program, University of Toronto, Toronto ON; Department of Medicine, Western University, London ON. 5. Obstetrical Medicine Program, University of Toronto, Toronto ON; Institute for Clinical Evaluative Sciences, Toronto ON; Department of Medicine and Obstetrics and Gynaecology, St. Michael's Hospital, Toronto ON.
Abstract
BACKGROUND: Women with preeclampsia may develop pulmonary edema, but the reasons for this are largely unknown. METHODS: We performed a case-control study of women with preeclampsia at two major obstetrical centres in Toronto, ON, between 2005 and 2012. Cases (n = 28) were women with preeclampsia who had pulmonary edema on a chest CT or plain X-ray during the index delivery hospitalization. Control subjects (n = 64) were those with preeclampsia but no diagnosis of pulmonary edema or heart failure in the index hospitalization for delivery. Study variables were abstracted from each woman's paper chart and electronic medical record. Multivariable logistic regression with backward elimination was used to select a final set of significant predictors. RESULTS: Approximately one half of the cases of pulmonary edema occurred antepartum. Each 10 × 10(9)/L reduction in platelet count (OR 1.32; 95% CI 1.06 to 1.65) or 10 µmol/ L increase in peak serum uric acid concentration (OR 1.19; 95% CI 1.06 to 1.34) was significantly associated with pulmonary edema, as was receiving magnesium sulphate (OR 10.42; 95% CI 1.39 to 78.22). Multiparity (OR 0.03; 95% CI 0.004 to 0.29) and each 500 mL increase in the volume of intravenous crystalloids received (OR 0.60; 95% CI 0.37 to 0.98) were associated with a lower risk of pulmonary edema. CONCLUSION: We identified several preliminary risk factors for pulmonary edema in women with preeclampsia. Additional work is needed to better understand the role of these and other factors predicting the development of pulmonary edema in women with preeclampsia.
BACKGROUND:Women with preeclampsia may develop pulmonary edema, but the reasons for this are largely unknown. METHODS: We performed a case-control study of women with preeclampsia at two major obstetrical centres in Toronto, ON, between 2005 and 2012. Cases (n = 28) were women with preeclampsia who had pulmonary edema on a chest CT or plain X-ray during the index delivery hospitalization. Control subjects (n = 64) were those with preeclampsia but no diagnosis of pulmonary edema or heart failure in the index hospitalization for delivery. Study variables were abstracted from each woman's paper chart and electronic medical record. Multivariable logistic regression with backward elimination was used to select a final set of significant predictors. RESULTS: Approximately one half of the cases of pulmonary edema occurred antepartum. Each 10 × 10(9)/L reduction in platelet count (OR 1.32; 95% CI 1.06 to 1.65) or 10 µmol/ L increase in peak serum uric acid concentration (OR 1.19; 95% CI 1.06 to 1.34) was significantly associated with pulmonary edema, as was receiving magnesium sulphate (OR 10.42; 95% CI 1.39 to 78.22). Multiparity (OR 0.03; 95% CI 0.004 to 0.29) and each 500 mL increase in the volume of intravenous crystalloids received (OR 0.60; 95% CI 0.37 to 0.98) were associated with a lower risk of pulmonary edema. CONCLUSION: We identified several preliminary risk factors for pulmonary edema in women with preeclampsia. Additional work is needed to better understand the role of these and other factors predicting the development of pulmonary edema in women with preeclampsia.
Authors: Arthur Jason Vaught; Lara C Kovell; Linda M Szymanski; Susan A Mayer; Sara M Seifert; Dhananjay Vaidya; Jamie D Murphy; Cynthia Argani; Anna O'Kelly; Sarah York; Pamela Ouyang; Monica Mukherjee; Sammy Zakaria Journal: J Am Coll Cardiol Date: 2018-07-03 Impact factor: 24.094
Authors: Lina Bergman; Karl Bergman; Eduard Langenegger; Ashley Moodley; Stephanie Griffith-Richards; Johan Wikström; David Hall; Lloyd Joubert; Philip Herbst; Sonja Schell; Teelkien van Veen; Michael Belfort; Stephen Y C Tong; Susan Walker; Roxanne Hastie; Catherine Cluver Journal: Cells Date: 2021-04-20 Impact factor: 6.600
Authors: L C Pfitscher; J G Cecatti; R C Pacagnella; S M Haddad; M A Parpinelli; J P Souza; S M Quintana; F G Surita; M H Sousa; M L Costa Journal: BMC Infect Dis Date: 2016-05-21 Impact factor: 3.090
Authors: Ana Carolina B Pordeus; Leila Katz; Mariana C Soares; Sabina B Maia; Melania M R Amorim Journal: Medicine (Baltimore) Date: 2018-07 Impact factor: 1.889